Welcome to LookChem.com Sign In|Join Free

CAS

  • or
2-Naphthalenecarboxylic acid, 3,5-dihydroxy-, methyl ester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

185989-39-3 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 185989-39-3 Structure
  • Basic information

    1. Product Name: 2-Naphthalenecarboxylic acid, 3,5-dihydroxy-, methyl ester
    2. Synonyms: 2-Naphthalenecarboxylic acid,3,5-dihydroxy-,methyl ester;methyl 3,5-dihydroxy-2-naphthoate;
    3. CAS NO:185989-39-3
    4. Molecular Formula: C12H10O4
    5. Molecular Weight: 218.209
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 185989-39-3.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 2-Naphthalenecarboxylic acid, 3,5-dihydroxy-, methyl ester(CAS DataBase Reference)
    10. NIST Chemistry Reference: 2-Naphthalenecarboxylic acid, 3,5-dihydroxy-, methyl ester(185989-39-3)
    11. EPA Substance Registry System: 2-Naphthalenecarboxylic acid, 3,5-dihydroxy-, methyl ester(185989-39-3)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 185989-39-3(Hazardous Substances Data)

185989-39-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 185989-39-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,5,9,8 and 9 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 185989-39:
(8*1)+(7*8)+(6*5)+(5*9)+(4*8)+(3*9)+(2*3)+(1*9)=213
213 % 10 = 3
So 185989-39-3 is a valid CAS Registry Number.

185989-39-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl 3,5-dihydroxynaphthalene-2-carboxylate

1.2 Other means of identification

Product number -
Other names methyl 3,5-dihydroxy-2-naphthoate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:185989-39-3 SDS

185989-39-3Relevant articles and documents

A synthetic receptor for asymmetric dimethyl arginine

James, Lindsey I.,Beaver, Joshua E.,Rice, Natalie W.,Waters, Marcey L.

, p. 6450 - 6455 (2013)

Dynamic combinatorial chemistry was utilized to identify a novel small molecule receptor, A2D, for asymmetric dimethyl arginine (aRMe 2), which is a post-translational modification (PTM) in proteins. It is known to play a role in a number of diseases, including spinal muscular atrophy, leukemia, lymphoma, and breast cancer. The receptor exhibits 2.5-7.5-fold selectivity over the isomeric symmetric dimethyl arginine, depending on the surrounding sequence, with binding affinities in the low micromolar range. The affinity and selectivity of A2D for the different methylated states of Arg parallels that of proteins that bind to these PTMs. Characterization of the receptor-PTM complex indicates that cation-π interactions provide the main driving force for binding, loosely mimicking the binding mode found in the recognition of dimethyl arginine by native protein receptors.

Bicyclic-Fused Heteroaryl or Aryl Compounds

-

Paragraph 0413, (2015/10/28)

Compounds, tautomers and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula Ia, as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

Enantioselective total synthesis of (S)-bisoranjidiol, an axially chiral bisanthraquinone

Podlesny, Erin E.,Kozlowski, Marisa C.

supporting information; experimental part, p. 1408 - 1411 (2012/06/01)

The first enantioselective total synthesis of the bisanthraquinone (S)-bisoranjidiol and an unnatural regioisomer has been accomplished. Key features of the synthesis include the asymmetric oxidative biaryl coupling of a hindered 8-substituted 2-naphthol,

Oxofunctionalized trans-2-carboxycinnamic acids by catalytic domino oxidation of naphthols and hydronaphthoquinones

Giurg, Miroslaw,Muchalski, Hubert,Kowal, Ewa

experimental part, p. 2526 - 2539 (2012/08/07)

(Chemical Equation Presented) The catalytic oxidation of naphthalenes was investigated. Hydrogen peroxide (30% aqueous) was used as an oxygen source, and 2,2′-dinitro-4,4′-ditrifluoromethyldiphenyl diselenide was the oxygen-transfer catalyst. Unsubstitute

Bicyclic compositions and methods for modulating a kinase cascade

-

Page/Page column 133-135, (2008/06/13)

The invention relates to compounds and methods for modulating one or more components of a kinase cascade.

Kinase inhibitors

-

Page/Page column 20-21, (2010/11/08)

The present invention provides a method for identifying inhibitors of protein kinases. Methods are also provided for inhibiting protein kinase activity. Specific non-peptide protein tyrosine kinase inhibitors are provided. The protein kinases produced usi

Photochromic compounds

-

Page 50, (2008/06/13)

Various non-limiting embodiments disclosed herein relate generally to photochromic compounds, which may be thermally reversible or non-thermally reversible, and articles made therefrom. Other non-limiting embodiments relate to photochromic-dichroic compounds, which may be thermally reversible or non-thermally reversible, and articles made therefrom. For example, one non-limiting embodiment provides a thermally reversible, photochromic compound adapted to have at least a first state and a second state, wherein the thermally reversible, photochromic compound has an average absorption ratio greater than 2.3 in at least one state as determined according to CELL METHOD. Another non-limiting embodiment provides a photochromic compound comprising: (a) at least one photochromic group chosen from a pyran, an oxazine, and a fulgide; and (b) at least one lengthening agent L attached to the at least one photochromic group and represented by the formula —[S1]c-[Q1-[S2]d]d′-[Q2-[S3]e]e′-[Q3-[S4]f]f′—S5—P, which is described herein.

Signal transduction inhibitors, compositions containing them

-

, (2008/06/13)

This invention concerns compounds for inhibiting intracellular signal transduction, especially intracellular signal transduction mediate by one or more molecular interactions involving a phosphotyrosine-containing protein. This invention also relates to p

The design, synthesis and activity of non-ATP competitive inhibitors of pp60(c-src) tyrosine kinase. Part 1: Hydroxynaphthalene derivatives

Marsilje, Thomas H.,Milkiewicz, Karen L.,Hangauer, David G.

, p. 477 - 481 (2007/10/03)

A series of hydroxynaphthalene pp60(c-src) non-peptide inhibitors was designed, using the crystal structure of the insulin receptor tyrosine kinase as a qualitative model, to target the peptide substrate binding site. Representative inhibitors were shown to bind non-competitively with respect to ATP. (C) 2000 Elsevier Science Ltd. All rights reserved.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 185989-39-3